Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jad Chahoud

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Nature Communications|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trialJeffrey S Johnson, Justin W Miller, Firas Hatoum, et al.
The Oncologist|August 18, 2022
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell CarcinomasJonathan Thouvenin, Omar Alhalabi, Maria Carlo, et al.
Journal for Immunotherapy of Cancer|May 15, 2023
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinomaNicholas H Chakiryan, Youngchul Kim, Anders Berglund, et al.
JCO Precision Oncology|January 9, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural VariationsEmily L Hoskins, Eric Samorodnitsky, Michele R Wing, et al.
Journal for Immunotherapy of Cancer|September 17, 2025
Germline whole-exome sequencing reveals <i>FOXP3</i>-related gene variants conferring urinary cancer susceptibility and associated with immune escapeBing-Jian Feng, Wendy Kohlmann, David A Nix, et al.
Journal of the National Cancer Institute|February 17, 2024
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world studyKyle M Rose, Rachel Pham, Niki M Zacharias, et al.
NPJ Precision Oncology|July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancersEmily L Hoskins, Raven Vella, Julie W Reeser, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironmentAlex C Soupir, Mitchell T Hayes, Taylor C Peak, et al.
The New England Journal of Medicine|July 1, 2026
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell CarcinomaToni K Choueiri, Robert J Motzer, Jose A Karam, et al.
Genome Biology|December 5, 2024
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironmentAlex C Soupir, Mitchell T Hayes, Taylor C Peak, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Nature Communications|May 25, 2026
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trialJeffrey S Johnson, Justin W Miller, Firas Hatoum, et al.
The Oncologist|August 18, 2022
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell CarcinomasJonathan Thouvenin, Omar Alhalabi, Maria Carlo, et al.
Journal for Immunotherapy of Cancer|May 15, 2023
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinomaNicholas H Chakiryan, Youngchul Kim, Anders Berglund, et al.
JCO Precision Oncology|January 9, 2023
Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural VariationsEmily L Hoskins, Eric Samorodnitsky, Michele R Wing, et al.
Journal for Immunotherapy of Cancer|September 17, 2025
Germline whole-exome sequencing reveals <i>FOXP3</i>-related gene variants conferring urinary cancer susceptibility and associated with immune escapeBing-Jian Feng, Wendy Kohlmann, David A Nix, et al.
Journal of the National Cancer Institute|February 17, 2024
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world studyKyle M Rose, Rachel Pham, Niki M Zacharias, et al.
NPJ Precision Oncology|July 3, 2025
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancersEmily L Hoskins, Raven Vella, Julie W Reeser, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironmentAlex C Soupir, Mitchell T Hayes, Taylor C Peak, et al.
The New England Journal of Medicine|July 1, 2026
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell CarcinomaToni K Choueiri, Robert J Motzer, Jose A Karam, et al.
Genome Biology|December 5, 2024
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear-cell renal-cell carcinoma tumor microenvironmentAlex C Soupir, Mitchell T Hayes, Taylor C Peak, et al.
Pageof 10